NEOG Stock Yearly Return 2018

This page is part of our 2018 average annual return archive: it shows the NEOG stock yearly return for calendar year 2018. This metric helps investors evaluate and compare performance among different stocks, over time.

Average annual return should be reviewed alongside overall market trends, and company fundamentals like earnings and revenue. As the saying goes on Wall St., past performance from 2018 does not guarantee future similar returns.

Stock Yearly Return 2018
Start date: 01/02/2018
End date: 12/31/2018
Start price/share: $30.08
End price/share: $28.50
Dividends collected/share: $0.00
Total return: -5.25%
NEOG Average Annual Return: -5.28%
Starting investment: $10,000.00
Ending investment: $9,475.00
Years: 0.99


NEOG average annual return is presented with the assumption of reinvestments of any dividends on ex-date.
Compare NEOG average annual return versus benchmarks:

S&P Average Annual Return
Dow Average Annual Return
Nasdaq 100 Average Annual Return
Russell 2000 Average Annual Return
Gold Average Annual Return
10 Year Treasury Average Annual Return
Growth of $10,000.00
Without Dividends Reinvested Into NEOG


Also see:
NEOG stock yearly return 2019
NEOG stock yearly return 2020
NEOG YTD return
NEOG average annual return 10 years
Neogen develops, manufactures, and markets a line of products for food and animal safety. Co.'s segments are: Food Safety, which is engaged in the development, production and marketing of diagnostic test kits and related products used by food producers and processors to detect harmful natural toxins, foodborne bacteria, allergens and levels of general sanitation; and Animal Safety, which is engaged in the development, production and marketing of products dedicated to animal safety, including a range of consumable products marketed to veterinarians and animal health product distributors, and provides genomic identification and related interpretive bioinformatic services. The NEOG stock yearly return is shown above.

The yearly return on the NEOG stock yearly return page and across the coverage universe of our site, is a measure of the annual return over the calendar year 2018 for the given stock. When performing this calculation it is important to factor in dividends, because a financial instrument's annual return is more than just the change in price if that instrument pays a dividend or coupon.

One way to factor dividends into the return is simply to count them as cash — we don't do that here. Instead, our website aims to empower investors by performing the NEOG annual return calculation with any dividends reinvested as applicable (on ex-dates).
Quotes delayed 20 minutes
Get Free SEC filing alerts for NEOG:
NEOG SEC Filing Email Alerts ServiceExternal link
10 Most Oversold Stocks in the S&P
10 Most Overbought Stocks in the S&P
10 ETFs With Stocks That Insiders Are Buying
10 ETFs With Most Upside To Analyst Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Energy Stocks You Can Buy Cheaper Than Insiders Did
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active Call & Put Options of the S&P 500 Components
Video: Don't Forget Dividends in Average Annual Return!


If the video does not load after a few moments, Upgrade to the Latest Flash Player.
Neogen (NEOG) is categorized under the Healthcare sector; to help you further research average annual return performance across stocks, below are some other companies in the same sector:

NEOS Average Annual Return
NERV Average Annual Return
NK Average Annual Return
NKTR Average Annual Return
NLNK Average Annual Return
NOVN Average Annual Return
NSPR Average Annual Return
NSTG Average Annual Return
NTLA Average Annual Return
NTRA Average Annual Return
More Healthcare companies »

 

NEOG Stock Yearly Return 2018 | www.AverageAnnualReturn.com | Copyright © 2021 - 2021, All Rights Reserved

Nothing in AverageAnnualReturn.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.